Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Röko AB (publ) in connection with the establishment of its MTN programme
Mandate

Vinge advises Röko AB (publ) in connection with the establishment of its MTN programme

November 13, 2026 Banking and Finance

Vinge has advised Röko AB (publ) ("Röko") on the establishment of a medium-term note programme (the "MTN Programme") with a framework amount of SEK 5 billion.

The MTN Programme forms part of Röko's debt financing and allows Röko to issue senior unsecured notes in SEK or EUR in an outstanding amount of up to SEK 5 billion (or the equivalent amount in EUR), with a minimum tenor of one year.

The base prospectus for the MTN Programme was approved by the Swedish Financial Supervisory Authority on 11 November 2026. SEB acts as arranger of the MTN Programme and, together with DNB Carnegie and Swedbank, as dealers.

Vinge’s team consisted of Lionardo Ojeda, Nilufer Nouri and Hilda Andreasson.

Related

Vinge has advised Course Corrected VC on the establishment of Course Corrected VC Fund II

 Vinge has advised Course Corrected VC on the establishment and structuring of their second fund, Course Corrected VC Fund II (the “Fund”).
November 12, 2026

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

 Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026